SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-16-000131
Filing Date
2016-09-08
Accepted
2016-09-07 17:33:10
Documents
14
Period of Report
2016-09-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k07sep2016.htm 8-K 23130
2 EXHIBIT 99.1 pr07sep16a.htm EX-99.1 22498
3 EXHIBIT 99.2 pr07sep16b.htm EX-99.2 15507
4 EXHIBIT 99.3 ljpc401phase1resultsandd.htm EX-99.3 11060
5 ljpc401phase1resultsandd001.jpg GRAPHIC 64705
6 ljpc401phase1resultsandd002.jpg GRAPHIC 329887
7 ljpc401phase1resultsandd003.jpg GRAPHIC 157640
8 ljpc401phase1resultsandd004.jpg GRAPHIC 119709
9 ljpc401phase1resultsandd005.jpg GRAPHIC 147619
10 ljpc401phase1resultsandd006.jpg GRAPHIC 87833
11 ljpc401phase1resultsandd007.jpg GRAPHIC 94800
12 ljpc401phase1resultsandd008.jpg GRAPHIC 126147
13 ljpc401phase1resultsandd009.jpg GRAPHIC 112203
14 ljpcpressrelease_image1a03.jpg GRAPHIC 21134
  Complete submission text file 0000920465-16-000131.txt   1800388
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 161874296
SIC: 2836 Biological Products, (No Diagnostic Substances)